Hot Biotech Trades for Second-Half 2011

Description:

According to Adam Feuerstein, these biotech trades "encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months." Read more here.

>>Also: 3 Funds' Best Stock Picks Ahead of Earnings

>>Also: 7 Best-Performing Dow Stocks

Most Viewed Portfolios

View All

Articles

5 Stocks Insiders Love Right Now

07.30.14 | 11:35 AM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. They might need the cash for a big pe...

Dividend Preview: 5 Stocks Ready to Pay You More

07.30.14 | 10:47 AM

BALTIMORE (Stockpickr) -- The S&P 500 may be pushing up against new all-time highs this month, but whatever you do, don't forget about dividends. ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter